syneos health uk limited

3.5

syneos health uk limited Company Information

Share SYNEOS HEALTH UK LIMITED
Live 
MatureMegaHigh

Company Number

04428083

Registered Address

farnborough business park, 1 pinehurst road, farnborough, hampshire, GU14 7BF

Industry

Other business support service activities n.e.c.

 

Telephone

01276713000

Next Accounts Due

September 2024

Group Structure

View All

Directors

Nyla Singh7 Years

Andrew Barron0 Years

Shareholders

syneos health holdings uk limited 100%

syneos health uk limited Estimated Valuation

£932m

Pomanda estimates the enterprise value of SYNEOS HEALTH UK LIMITED at £932m based on a Turnover of £1b and 0.93x industry multiple (adjusted for size and gross margin).

syneos health uk limited Estimated Valuation

£474.1m

Pomanda estimates the enterprise value of SYNEOS HEALTH UK LIMITED at £474.1m based on an EBITDA of £67.3m and a 7.04x industry multiple (adjusted for size and gross margin).

syneos health uk limited Estimated Valuation

£801.9m

Pomanda estimates the enterprise value of SYNEOS HEALTH UK LIMITED at £801.9m based on Net Assets of £346.7m and 2.31x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Syneos Health Uk Limited AI Business Plan

In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.

View Sample

Syneos Health Uk Limited Overview

Syneos Health Uk Limited is a live company located in farnborough, GU14 7BF with a Companies House number of 04428083. It operates in the other business support service activities n.e.c. sector, SIC Code 82990. Founded in April 2002, it's largest shareholder is syneos health holdings uk limited with a 100% stake. Syneos Health Uk Limited is a mature, mega sized company, Pomanda has estimated its turnover at £1b with high growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Syneos Health Uk Limited Health Check

Pomanda's financial health check has awarded Syneos Health Uk Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating3.5out of 5
positive_score

4 Strong

positive_score

2 Regular

positive_score

5 Weak

size

Size

annual sales of £1b, make it larger than the average company (£3.7m)

£1b - Syneos Health Uk Limited

£3.7m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 23%, show it is growing at a faster rate (3%)

23% - Syneos Health Uk Limited

3% - Industry AVG

production

Production

with a gross margin of 20.8%, this company has a higher cost of product (38.9%)

20.8% - Syneos Health Uk Limited

38.9% - Industry AVG

profitability

Profitability

an operating margin of 6.5% make it as profitable than the average company (6.3%)

6.5% - Syneos Health Uk Limited

6.3% - Industry AVG

employees

Employees

with 1241 employees, this is above the industry average (25)

1241 - Syneos Health Uk Limited

25 - Industry AVG

paystructure

Pay Structure

on an average salary of £79.8k, the company has a higher pay structure (£50.5k)

£79.8k - Syneos Health Uk Limited

£50.5k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £806.8k, this is more efficient (£157.8k)

£806.8k - Syneos Health Uk Limited

£157.8k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 53 days, this is later than average (44 days)

53 days - Syneos Health Uk Limited

44 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 2 days, this is quicker than average (33 days)

2 days - Syneos Health Uk Limited

33 days - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Syneos Health Uk Limited

- - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (24 weeks)

0 weeks - Syneos Health Uk Limited

24 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 66%, this is a similar level of debt than the average (63.6%)

66% - Syneos Health Uk Limited

63.6% - Industry AVG

syneos health uk limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for syneos health uk limited. Get real-time insights into syneos health uk limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Syneos Health Uk Limited Competitor Analysis

BETA
competitor_analysis_table_img

Perform a competitor analysis for syneos health uk limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.

syneos health uk limited Ownership

SYNEOS HEALTH UK LIMITED group structure

Syneos Health Uk Limited has 3 subsidiary companies.

Ultimate parent company

JOURNEYBEGINS LLC

#0149677

2 parents

SYNEOS HEALTH UK LIMITED

04428083

3 subsidiaries

SYNEOS HEALTH UK LIMITED Shareholders

syneos health holdings uk limited 100%

syneos health uk limited directors

Syneos Health Uk Limited currently has 2 directors. The longest serving directors include Ms Nyla Singh (Apr 2017) and Mr Andrew Barron (Sep 2023).

officercountryagestartendrole
Ms Nyla SinghEngland61 years Apr 2017- Director
Mr Andrew BarronEngland48 years Sep 2023- Director

SYNEOS HEALTH UK LIMITED financials

EXPORTms excel logo

Syneos Health Uk Limited's latest turnover from December 2022 is £1 billion and the company has net assets of £346.7 million. According to their latest financial statements, Syneos Health Uk Limited has 1,241 employees and maintains cash reserves of £1.5 million as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Turnover1,001,250,000871,822,000797,814,829539,409,673461,180,080440,507,926404,116,452225,777,224148,110,634112,762,16087,867,89967,409,98267,119,30949,413,461
Other Income Or Grants00000000000000
Cost Of Sales792,961,000707,171,000676,063,637389,229,067375,084,993340,110,614297,765,302167,778,286111,241,71393,627,98074,146,01053,238,15355,347,02133,729,553
Gross Profit208,289,000164,651,000121,751,192150,180,60686,095,087100,397,312106,351,15057,998,93836,868,92119,134,18013,721,88914,171,82911,772,28815,683,908
Admin Expenses142,852,000113,619,00090,520,01697,996,33256,821,59763,941,24964,322,90721,040,90821,254,00512,458,57216,286,8179,105,4147,058,21810,270,956
Operating Profit65,437,00051,032,00031,231,17652,184,27429,273,49036,456,06342,028,24336,958,03015,614,9166,675,608-2,564,9285,066,4154,714,0705,412,952
Interest Payable970,000839,0002,184,61518,634,4156,552,873121,92564,56672,854157,545539,731519,8350354,055260,949
Interest Receivable596,000651,0002,399,46711,840,0758,960,7102,238,9981,404,563999,1131,320,247295,703540,637502,35598,16812,527
Pre-Tax Profit42,776,00081,745,000-838,555,55543,347,49823,717,53530,695,89143,339,10527,957,03016,777,6186,431,580-2,544,1265,864,8804,458,1835,164,530
Tax-4,378,000-4,291,000-2,214,404-2,564,169-5,135,532-4,970,452-6,991,488-5,835,7242,257,504-316,219-13,693-127,749-79,358-144,913
Profit After Tax38,398,00077,454,000-840,769,95940,783,32918,582,00325,725,43936,347,61722,121,30619,035,1226,115,361-2,557,8195,737,1314,378,8255,019,617
Dividends Paid083,946,00059,074,50143,558,33770,734,1533,273,3102,319,90414,938,3381,400,00004,665,46803,700,0000
Retained Profit38,398,000-6,492,000-899,844,460-2,775,008-52,152,15022,452,12934,027,7137,182,96817,635,1226,115,361-7,223,2875,737,131678,8255,019,617
Employee Costs99,062,00091,732,00086,077,58158,842,17647,969,86449,505,20844,644,12036,517,58832,878,12025,546,07619,866,36614,504,67212,824,81510,759,685
Number Of Employees1,2411,1891,204837705766742656604493404298284262
EBITDA*67,301,00052,591,00032,611,68153,596,01538,220,28345,063,49850,594,90539,204,18117,798,8778,528,441-725,3625,281,8185,164,4885,873,316

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Tangible Assets5,550,0005,581,0006,198,9736,465,8757,387,0921,021,5831,083,5451,348,1371,720,0121,484,8191,393,981371,243421,165337,218
Intangible Assets6,00027,00013,74372,471159,0178,089,36915,754,49123,631,73611,645,36910,601,58711,926,78500350,403
Investments & Other569,266,000550,681,000498,960,0831,419,957,72391,03691,03691,03591,232107,7708282880
Debtors (Due After 1 year)3,662,0003,477,000731,14871,76566,218187,334365,895256,607289,053004,543,6524,431,3970
Total Fixed Assets578,484,000559,766,000505,903,9471,426,567,8347,703,3639,389,32217,294,96625,327,71213,762,20412,086,48813,320,8484,914,9034,852,570687,621
Stock & work in progress00000000000000
Trade Debtors145,667,000121,994,000105,514,26077,056,34672,294,67850,444,84066,606,68435,858,82618,410,3758,304,6348,542,88513,988,8389,437,75513,779,175
Group Debtors58,799,00034,642,00060,735,29168,691,341116,429,4000064,059,70347,666,87659,873,90835,986,77017,977,2253,721,6921,194,958
Misc Debtors235,834,000164,935,000152,933,79458,844,46653,012,604145,090,485114,045,26036,572,41519,589,76411,485,48416,289,90214,297,8819,573,20812,854,141
Cash1,482,0005,091,00016,685,3314,327,72929,962,64773,580,01449,238,8149,110,68326,196,9713,179,8103,660,3223,076,4365,576,26614,568,867
misc current assets00000000000000
total current assets441,782,000326,662,000335,868,676208,919,882271,699,329269,115,339229,890,758145,601,627111,863,98682,843,83664,479,87949,340,38028,308,92142,397,141
total assets1,020,266,000886,428,000841,772,6231,635,487,716279,402,692278,504,661247,185,724170,929,339125,626,19094,930,32477,800,72754,255,28333,161,49143,084,762
Bank overdraft9,079,0000015,467,96100000002410441,701
Bank loan00000000000000
Trade Creditors 5,420,0004,249,0004,612,9068,213,4176,127,2362,495,6241,247,3182,142,8861,177,4381,197,2392,725,1125,596,6293,545,518375,580
Group/Directors Accounts251,193,000575,481,000567,815,507155,310,195115,351,48197,750,36895,451,17658,876,87256,266,91258,431,55340,439,88415,279,0313,185,44816,435,957
other short term finances00000000000000
hp & lease commitments000000000000012,871
other current liabilities66,142,00071,473,00078,957,90493,568,467139,566,32179,475,94375,934,17970,178,18935,592,87321,110,78617,416,62418,551,37317,339,64721,645,680
total current liabilities331,834,000651,203,000651,386,317272,560,040261,045,038179,721,935172,632,673131,197,94793,037,22380,739,57860,581,62039,427,27424,070,61338,911,789
loans334,504,000000000303,546540,57309,614,385000
hp & lease commitments00000000000000
Accruals and Deferred Income00000000000000
other liabilities00000000000000
provisions7,243,0004,310,0005,357,6511,039,0701,069,088678,500509,874280,873202,19900000
total long term liabilities341,747,0004,310,0005,357,6511,039,0701,069,088678,500509,874584,419742,77209,614,385000
total liabilities673,581,000655,513,000656,743,968273,599,110262,114,126180,400,435173,142,547131,782,36693,779,99580,739,57870,196,00539,427,27424,070,61338,911,789
net assets346,685,000230,915,000185,028,6551,361,888,60617,288,56698,104,22674,043,17739,146,97331,846,19514,190,7467,604,72214,828,0099,090,8784,172,973
total shareholders funds346,685,000230,915,000185,028,6551,361,888,60617,288,56698,104,22674,043,17739,146,97331,846,19514,190,7467,604,72214,828,0099,090,8784,172,973
Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Operating Activities
Operating Profit65,437,00051,032,00031,231,17652,184,27429,273,49036,456,06342,028,24336,958,03015,614,9166,675,608-2,564,9285,066,4154,714,0705,412,952
Depreciation1,843,0001,559,0001,380,5051,325,195983,001716,115689,417657,733595,543527,635514,368215,403244,624401,963
Amortisation21,0000086,5467,963,7927,891,3207,877,2451,588,4181,588,4181,325,1981,325,1980205,79458,401
Tax-4,378,000-4,291,000-2,214,404-2,564,169-5,135,532-4,970,452-6,991,488-5,835,7242,257,504-316,219-13,693-127,749-79,358-144,913
Stock00000000000000
Debtors118,914,0005,133,507115,250,575-37,138,98246,080,24114,704,82044,270,28850,791,4836,292,04218,844,46910,011,96123,643,544-664,22227,828,274
Creditors1,171,000-363,906-3,600,5112,086,1813,631,6121,248,306-895,568965,448-19,801-1,527,873-2,871,5172,051,1113,169,938375,580
Accruals and Deferred Income-5,331,000-7,484,904-14,610,563-45,997,85460,090,3783,541,7645,755,99034,585,31614,482,0873,694,162-1,134,7491,211,726-4,306,03321,645,680
Deferred Taxes & Provisions2,933,000-1,047,6514,318,581-30,018390,588168,626229,00178,674202,19900000
Cash flow from operations-57,218,00034,270,032-98,745,79144,229,13751,117,08830,346,9224,422,55218,206,41228,428,824-8,465,958-14,757,282-15,226,6384,613,257-78,611
Investing Activities
capital expenditure-1,812,000-954,284-1,054,875-403,978-7,381,950-880,351-424,825-13,860,643-3,462,936-618,473-14,789,089-165,481-183,962-1,147,985
Change in Investments18,585,00051,720,917-920,997,6401,419,866,68701-197-16,538107,688074080
cash flow from investments-20,397,000-52,675,201919,942,765-1,420,270,665-7,381,950-880,352-424,628-13,844,105-3,570,624-618,473-14,789,163-165,481-183,970-1,147,985
Financing Activities
Bank loans00000000000000
Group/Directors Accounts-324,288,0007,665,493412,505,31239,958,71417,601,1132,299,19236,574,3042,609,960-2,164,64117,991,66925,160,85312,093,583-13,250,50916,435,957
Other Short Term Loans 00000000000000
Long term loans334,504,00000000-303,546-237,027540,573-9,614,3859,614,385000
Hire Purchase and Lease Commitments000000000000-12,87112,871
other long term liabilities00000000000000
share issue77,372,00052,378,345-277,015,4911,347,375,048-28,663,5101,608,920868,491117,81020,327470,663004,239,080-846,644
interest-374,000-188,000214,852-6,794,3402,407,8372,117,0731,339,997926,2591,162,702-244,02820,802502,355-255,887-248,422
cash flow from financing87,214,00059,855,838135,704,6731,380,539,422-8,654,5606,025,18538,479,2463,417,002-441,0398,603,91934,796,04012,595,938-9,280,18715,353,762
cash and cash equivalents
cash-3,609,000-11,594,33112,357,602-25,634,918-43,617,36724,341,20040,128,131-17,086,28823,017,161-480,512583,886-2,499,830-8,992,60114,568,867
overdraft9,079,0000-15,467,96115,467,961000000-241241-441,701441,701
change in cash-12,688,000-11,594,33127,825,563-41,102,879-43,617,36724,341,20040,128,131-17,086,28823,017,161-480,512584,127-2,500,071-8,550,90014,127,166

P&L

December 2022

turnover

1b

+15%

operating profit

65.4m

+28%

gross margin

20.9%

+10.15%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2022

net assets

346.7m

+0.5%

total assets

1b

+0.15%

cash

1.5m

-0.71%

net assets

Total assets minus all liabilities

syneos health uk limited company details

company number

04428083

Type

Private limited with Share Capital

industry

82990 - Other business support service activities n.e.c.

incorporation date

April 2002

age

22

accounts

Full Accounts

ultimate parent company

JOURNEYBEGINS LLC

previous names

inc research uk limited (January 2019)

inc research europe limited (January 2010)

See more

incorporated

UK

address

farnborough business park, 1 pinehurst road, farnborough, hampshire, GU14 7BF

last accounts submitted

December 2022

syneos health uk limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 5 charges/mortgages relating to syneos health uk limited. Currently there are 5 open charges and 0 have been satisfied in the past.

charges

syneos health uk limited Companies House Filings - See Documents

datedescriptionview/download